Home/Rare Diseases/Ehlers-Danlos Syndrome

Connective Tissue & Musculoskeletal

Ehlers-Danlos Syndrome

Also called EDS, Ehlers Danlos

Ehlers-Danlos syndrome (EDS) encompasses a group of genetic connective tissue disorders caused by mutations affecting collagen synthesis, structure, or processing. At least 13 subtypes are recognized, each with distinct genetic basis and clinical features.

...active trials

Live from ClinicalTrials.gov

View trials below

About trials for Ehlers-Danlos Syndrome

Clinical trials for EDS are evaluating pain management strategies, approaches to improve wound healing and reduce skin fragility, and targeted therapies for specific EDS subtypes. The Ehlers-Danlos Society and patient organizations provide comprehensive resources and trial information.

Try Match Me →

About Ehlers-Danlos Syndrome

Ehlers-Danlos syndrome (EDS) encompasses a group of genetic connective tissue disorders caused by mutations affecting collagen synthesis, structure, or processing. At least 13 subtypes are recognized, each with distinct genetic basis and clinical features. The most common classical EDS results from type V collagen mutations and features hyperextensible skin, joint hypermobility, poor wound healing, and characteristic skin texture (velvety or doughy). Vascular EDS, caused by type III collagen mutations (COL3A1), is the most serious, characterized by thin translucent skin, easy bruising, severe joint hypermobility, and life-threatening complications including spontaneous aortic and arterial aneurysms, arterial rupture, and gastrointestinal perforation. The combination of joint instability and tissue fragility creates challenges for treatment and high risk of complications. Molecular understanding of EDS subtypes has improved, allowing for genotype-phenotype correlation and tailored management strategies.

Common Symptoms

  • Overly flexible joints (hypermobility) with dislocations
  • Hyperextensible, velvety skin with poor wound healing
  • Easy bruising and fragile tissues
  • Aortic and arterial aneurysms in vascular EDS
  • Gastrointestinal complications including perforations in vascular EDS
  • Chronic pain and fatigue

Who It Affects

Various subtypes with different inheritance patterns; most are autosomal dominant. Classical EDS (formerly Type I and II) most common; vascular EDS (Type IV) most serious. Affects males and females equally.

Getting Involved in Clinical Trials

Clinical trials for EDS are evaluating pain management strategies, approaches to improve wound healing and reduce skin fragility, and targeted therapies for specific EDS subtypes. The Ehlers-Danlos Society and patient organizations provide comprehensive resources and trial information. Multidisciplinary management is essential, including dermatology, rheumatology, cardiology (especially for vascular EDS), physical therapy, and pain management. Genetic testing to determine EDS subtype is important for prognosis and management. Screening for vascular complications is crucial in vascular EDS, with regular vascular imaging and beta-blocker therapy to reduce aortic rupture risk. Discuss with your care team about clinical trials and emerging therapies that might improve pain, mobility, and quality of life.

Trusted Sources

Active Clinical Trials for Ehlers-Danlos Syndrome

Finding trials for Ehlers-Danlos Syndrome...

Related Connective Tissue & Musculoskeletal Conditions

Connective Tissue & Musculoskeletal

Marfan Syndrome

Marfan syndrome is an autosomal dominant genetic disorder affecting connective tissue throughout the body, caused by mut...

Connective Tissue & Musculoskeletal

Osteogenesis Imperfecta

Osteogenesis imperfecta is a genetic disorder affecting type I collagen synthesis or structure, causing bones to break e...